Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma

There is no standard third-line or further systemic treatment for patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma (NPC). Metronomic oral cyclophosphamide provides an acceptable and cheap option for these heavily pretreated patients who had limited ch...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Medicine (Baltimore)
Главные авторы: Lee, Victor H.F., Kwong, Dora L.W., Lam, Ka-On, Lai, Yu-Ching, Li, Yun, Tong, Chi-Chung, Ho, Patty P.Y., Chan, Wing-Lok, Wong, Lai-San, Leung, Dennis K.C., Chan, Sum-Yin, Chan, Fong-Ting, Leung, To-Wai, Lee, Anne W.M.
Формат: Artigo
Язык:Inglês
Опубликовано: Wolters Kluwer Health 2017
Предметы:
5700
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403079/
https://ncbi.nlm.nih.gov/pubmed/28403082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006518
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы